Michael W. Hunkapiller

Michael W. Hunkapiller (* 1948 in Oklahoma ) is an American bioengineer . He is known for developing devices for the automation of DNA sequencing (together with Leroy Hood ; see sequencing machine ) and for artificial gene synthesis .

Hunkapiller earned a bachelor's degree in chemistry from Oklahoma Baptist University in 1970 and a Ph.D. from CalTech in 1974. in biochemistry . He worked for Applied Biosciences (now Thermo Fisher Scientific ) from 1983 , from 1995 to 2004 as President and General Manager . After his involvement in the venture capital -Unternehmen Alloy 2004 was Hunkapiller of Directors of since 2005. Biotechnology -Unternehmens Pacific Biosciences in Menlo Park , California . He has been the company's President and CEO since 2012 . He was one of the founders of Celera Genomics (along with Craig Venter ) and was in charge of its parent company Applera Corporation , which in turn belonged to PerkinElmer .

In 1991 Hunkapiller was elected to the American Association for the Advancement of Science , and in 2008 to the National Academy of Engineering .

Since 2019, the media group Clarivate has counted him among the favorites for a Nobel Prize in chemistry due to the number of his citations . According to the Scopus database , Hunkapiller (as of October 2019) has an h-index of 45.

Web links

• Michael Hunkapiller, Ph.D. at Pacific Biosciences (pacb.com)
• Piero Scaruffi : Michael Hunkapiller . In: A History of Silicon Valley (scaruffi.com)

Individual evidence

1. ↑ ^{a b} Dr. Michael W. Hunkapiller. In: nae.edu. National Academy of Engineering , accessed October 11, 2019 . 
2. ^ The Web of Science Group Reveals Annual Citation Laureates of 'Nobel Class'. In: clarivate.com. Clarivate Analytics, September 24, 2019, accessed October 11, 2019 . 
3. ↑ Hunkapiller, Michael W. In: scopus.com. Scopus , accessed October 11, 2019 .